◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
百诚医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 802.0M 1.0B 607.0M 374.0M 207.0M 156.0M 82.1M 25.6M 23.8M 16.2M 6.0M 3.0M
Revenue Growth % -21.1% 67.5% 62.3% 80.7% 32.7% 90.0% 221.0% 7.5% 46.8% 172.2% 99.1% --
Total Revenue 802.0M 1.0B 607.0M 374.0M 207.0M 156.0M 82.1M 25.6M 23.8M 16.2M 6.0M 3.0M
Cost Of Revenue 385.0M 351.0M 198.0M 123.0M 70.9M 59.1M 37.7M 15.4M 8.5M 5.0M 4.6M 2.0M
+Gross Profit 417.0M 666.0M 409.0M 251.0M 136.1M 96.9M 44.4M 10.2M 15.3M 11.2M 1.4M 965,500
Gross Margin % 52.0% 65.5% 67.4% 67.1% 65.8% 62.1% 54.0% 39.7% 64.2% 69.3% 23.3% 32.3%
Total Operating Cost 851.0M 737.0M 444.0M 264.0M 154.0M 108.0M 73.1M 34.2M 21.0M 9.3M 8.1M 4.2M
Selling Expenses 15.0M 9.7M 7.8M 6.7M 1.9M 3.8M 3.2M 483,600 204,300 126,800 51,300 54,200
Admin Expenses 77.5M 129.0M 101.0M 47.9M 44.6M 29.2M 18.1M 9.3M 11.8M 5.0M 3.1M 1.8M
Rd Expenses 318.0M 241.0M 166.0M 81.1M 33.5M 15.7M 12.4M 8.5M -- -- -- --
Finance Expenses 4.2M -21.2M -41.8M 881,200 66,600 -597,000 597,000 419,200 239,000 22,200 2,000 1,200
+Operating Income -34.4M 297.0M 189.0M 119.0M 64.8M 51.1M 12.1M -9.1M 2.0M 6.0M -2.2M -1.2M
Operating Margin % -4.3% 29.2% 31.1% 31.8% 31.3% 32.7% 14.7% -35.6% 8.5% 37.2% -36.5% -38.8%
Non Operating Income 400,800 384,700 2.4M 145,600 1.0M 300.00 3,700 250,000 1.5M 30,000 100,000 118,200
Non Operating Expenses 2.1M 1.7M 165,800 187,400 652,800 31,600 21,600 337,900 12,100 45,900 9,500 7,300
Investment Income -5.6M -107,900 -1.1M -650,700 955,200 551,200 2.9M -622,300 -802,100 -855,800 -- --
Fair Value Change Income -- -- -2.9M -- -- -- -- -- -- -- -- --
Asset Disposal Income -- 780,700 15,200 -- -- -1,900 -- -- -- -- -- --
Asset Impairment Loss 10.1M 12.9M 2.9M 1.4M 1.0M -- 872,100 114,800 166,900 -816,100 433,700 275,200
Other Income 20.2M 16.2M 29.4M 9.7M 10.4M 2.4M 181,000 160,000 -- -- -- --
Income Before Tax -36.1M 296.0M 191.0M 119.0M 65.1M 51.0M 12.1M -9.2M 3.5M 6.0M -2.1M -1.1M
Income Tax 16.9M 23.7M -3.1M 8.0M 7.9M 6.0M 610,600 -1.8M 373,200 1.1M -466,300 -149,900
+Net Income -52.9M 272.0M 194.0M 111.0M 57.2M 45.0M 11.5M -7.4M 3.1M 4.9M -1.6M -900,500
Net Margin % -6.6% 26.7% 32.0% 29.7% 27.6% 28.9% 14.0% -28.9% 13.0% 30.4% -27.2% -30.1%
Net Income Attributable -52.7M 272.0M 194.0M 111.0M 57.4M 44.4M 11.0M -7.1M 3.1M 4.9M -1.6M -900,500
Minority Interest -180,200 48,600 -121,400 -118,800 -210,200 624,000 432,900 -280,100 -48,400 -- -- --
Eps Basic -0.49 2.51 1.80 1.37 0.71 0.60 0.18 -0.12 0.27 0.51 -0.23 -0.90
Eps Diluted -0.49 2.51 1.79 1.37 0.71 0.60 0.18 -0.12 0.27 0.51 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 429.0M 882.0M 1.2B 2.0B 134.0M 189.0M 79.3M 14.0M 1.8M 4.6M 33,100 70,000
Trading Financial Assets 83.0M -- -- -- -- -- -- -- -- -- -- --
Accounts Receivable 361.0M 200.0M 150.0M 76.8M 34.5M 26.8M 13.6M 3.2M 4.2M 301,300 41,200 --
Notes Receivable -- 13.3M 2.4M 456,000 9.2M -- -- 450,000 -- -- -- --
Notes And Accounts Receivable 361.0M 213.0M 152.0M 77.2M 43.7M 26.8M 13.6M 3.6M 4.2M 301,300 41,200 --
Prepayments 32.4M 42.3M 24.0M 13.2M 10.0M 3.2M 3.5M 3.6M 9.2M 11.2M 401,800 545,200
Inventory 177.0M 93.2M 66.1M 22.9M 3.6M 2.5M 1.6M 943,500 407,000 287,000 169,600 74,600
Total Current Assets 1.5B 1.6B 1.6B 2.2B 239.0M 233.0M 110.0M 27.5M 16.6M 16.8M 2.4M 2.6M
Long Term Equity Investment 35.1M 16.4M -- 765,400 1.7M -- 282,300 7.4M 4.8M 5.1M -- --
Fixed Assets -- 1.3B 522.0M 447.0M 66.8M 47.2M 35.9M 24.1M 11.7M 4.6M 4.0M 3.1M
Fixed Assets Total 1.6B 1.3B 522.0M 447.0M 66.8M 47.2M 35.9M 24.1M 11.7M 4.6M 4.0M 3.1M
Construction In Progress -- 448.0M 546.0M 104.0M 187.0M 6.2M -- -- -- -- -- --
Construction In Progress Total 207.0M 449.0M 546.0M 104.0M 187.0M 6.2M -- -- -- -- -- --
Intangible Assets 93.4M 92.1M 82.4M 60.8M 62.0M 57.0M 1.3M 2.4M 58,500 -- -- --
Long Term Deferred Expenses 1.4M 246,600 4.0M 14.4M 18.3M 6.3M 5.2M 5.0M 1.6M 1.1M 1.3M 1.5M
Total Non Current Assets 2.2B 2.1B 1.3B 699.0M 401.0M 146.0M 46.3M 49.5M 18.6M 11.4M 6.6M 5.2M
Total Assets 3.7B 3.7B 2.9B 2.9B 640.0M 379.0M 156.0M 77.0M 35.2M 28.1M 9.1M 7.8M
Short Term Borrowings 360.0M 369.0M -- 5.0M 19.0M -- 12.0M 12.0M 5.0M 500,000 -- --
Accounts Payable 135.0M 220.0M 139.0M 130.0M 34.0M 3.8M 2.3M 1.2M 1.0M 864,300 1.7M 2.8M
Advance Receipts -- -- -- -- -- 60.6M 44.7M 27.8M 10.1M 12.5M 6.4M 4.9M
Contract Liabilities 112.0M 74.0M 62.6M 71.2M 50.4M -- -- -- -- -- -- --
Total Current Liabilities 769.0M 846.0M 291.0M 473.0M 122.0M 74.3M 67.9M 45.1M 18.1M 14.7M 10.8M 10.1M
Long Term Borrowings 244.0M -- -- 40.4M 135.0M -- -- -- -- -- -- --
Total Non Current Liabilities 372.0M 139.0M 157.0M 134.0M 178.0M 25.6M 13.0M 4.4M 182,600 403,000 357,300 --
Total Liabilities 1.1B 985.0M 447.0M 607.0M 300.0M 99.9M 80.9M 49.5M 18.3M 15.1M 11.2M 10.1M
Paid In Capital 109.0M 109.0M 108.0M 108.0M 81.1M 81.1M 44.2M 13.7M 11.5M 11.5M 2.8M 1.0M
Capital Reserve 2.1B 2.1B 2.1B 2.0B 186.0M 173.0M 36.4M 30.7M 210,500 210,500 -- --
Surplus Reserve 54.6M 54.5M 42.8M 20.7M 9.0M 3.3M -- -- 344,600 1,300 -- --
Retained Earnings 359.0M 444.0M 270.0M 163.0M 64.5M 20.9M -6.6M -17.7M 4.1M 1.3M -4.9M -3.3M
Minority Equity -- -- -258,600 -137,200 -18,400 288,500 1.3M 747,800 731,600 -- -- --
Equity Attributable 2.6B 2.7B 2.5B 2.3B 340.0M 278.0M 74.1M 26.7M 16.2M 13.0M -2.1M -2.3M
Total Equity 2.6B 2.7B 2.5B 2.3B 340.0M 279.0M 75.3M 27.5M 16.9M 13.0M -2.1M -2.3M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 575.0M 687.0M 542.0M 384.0M 179.0M 171.0M 99.9M 39.0M 17.4M 17.8M 7.6M 4.2M
Tax Refunds Received 33.2M 28.4M 67.9M -- 1.1M -- -- -- -- -- -- --
Total Operating Cash Inflow 652.0M 809.0M 684.0M 398.0M 194.0M 175.0M 103.0M 43.9M 24.6M 20.2M 7.9M 5.3M
Cash Paid For Goods 317.0M 264.0M 102.0M 83.4M 37.1M 19.4M 13.5M 4.9M 2.7M 7.3M 2.0M 828,400
Cash Paid To Employees 343.0M 275.0M 189.0M 108.0M 67.1M 45.4M 24.3M 12.9M 6.9M 4.5M 2.7M 1.2M
Taxes Paid 28.0M 29.3M 26.0M 16.8M 9.0M 13.3M 2.7M 803,100 81,900 306,000 27,500 23,700
Total Operating Cash Outflow 848.0M 719.0M 425.0M 253.0M 140.0M 104.0M 57.3M 33.2M 22.5M 17.6M 6.7M 3.1M
Operating Cash Flow -196.0M 90.5M 259.0M 145.0M 54.4M 71.5M 45.4M 10.7M 2.0M 2.6M 1.1M 2.2M
Total Investing Cash Inflow 473.0M 140.0M 7.9M 91.3M 172.0M 275.0M 41.9M -- -- -- -- --
Total Investing Cash Outflow 937.0M 907.0M 699.0M 342.0M 428.0M 379.0M 57.4M 34.0M 9.8M 8.7M 3.0M 2.4M
Investing Cash Flow -465.0M -767.0M -691.0M -251.0M -256.0M -104.0M -15.5M -34.0M -9.8M -8.7M -3.0M -2.4M
Cash From Borrowings 1.2B 469.0M 300.0M 132.0M 163.0M -- 24.0M 17.0M 5.0M 1.0M -- --
Dividends And Interest Paid 48.8M 92.8M 66.6M 10.1M 8.7M 13.9M 940,100 4.6M 239,800 25,700 -- --
Debt Repayments 905.0M 100.0M 567.0M 19.0M 9.0M 12.0M 24.0M 10.0M 500,000 500,000 -- --
Total Financing Cash Inflow 1.3B 491.0M 300.0M 2.0B 163.0M 168.0M 60.4M 52.3M 5.8M 11.2M 1.8M --
Total Financing Cash Outflow 956.0M 246.0M 666.0M 40.3M 18.0M 25.9M 24.9M 16.9M 739,800 525,700 -- --
Financing Cash Flow 298.0M 244.0M -366.0M 2.0B 145.0M 142.0M 35.4M 35.4M 5.0M 10.7M 1.8M --
Net Change In Cash -362.0M -433.0M -798.0M 1.9B -56.2M 109.0M 65.3M 12.2M -2.7M 4.5M -36,900 -147,600
Ending Cash Balance 416.0M 778.0M 1.2B 2.0B 133.0M 189.0M 79.3M 14.0M 1.8M 4.6M 33,100 70,000
Capex 395.0M 689.0M 592.0M 248.0M 255.0M 107.0M 19.4M 31.0M 9.3M 2.7M 3.0M 2.4M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...